FDA Files Lawsuit Against Vape Junkie Ejuice for Unauthorized E-cigarette Sales

Regulations by 2FIRSTS.ai
Dec.05.2023
FDA Files Lawsuit Against Vape Junkie Ejuice for Unauthorized E-cigarette Sales
FDA files permanent injunction lawsuit against Vape Junkie Ejuice for unauthorized production and distribution of e-cigarette products.

According to a statement released by the US Food and Drug Administration (FDA) on December 4th, the FDA has filed a lawsuit through the US Department of Justice (DOJ) against e-cigarette liquid retailer Vape Junkie Ejuice, seeking a permanent injunction. The reason for the legal action is their production, sale, and distribution of unauthorized e-cigarette products.

FDA Files Lawsuit Against Vape Junkie Ejuice for Unauthorized E-cigarette Sales
Image source: 2FIRSTS

 

This case marks the FDA's seventh initiation of a ban enforcement procedure to carry out the pre-market review requirements of the Federal Food, Drug, and Cosmetic Act (FD&C Act) pertaining to novel tobacco products.

 

The FDA reports that despite issuing a warning to Vape Junkie Ejuice and threatening potential further actions, including a ban, the company continues to illicitly produce, sell, and distribute unauthorized e-cigarette products to consumers.

 

In response to this issue, Brian King, the Director of the Center for Tobacco Products (CTP) at the FDA, stated:

 

The FDA is very clear that we will not tolerate individuals openly disregarding the law, especially after being warned.

 

Currently, the Department of Justice (DOJ) has filed a lawsuit on behalf of the Food and Drug Administration (FDA), seeking an injunction against Vape Junkie Ejuice. The lawsuit demands that Vape Junkie Ejuice cease the production, sale, and distribution of their e-cigarette liquid and obtain market authorization from the FDA before selling such products.

 

Ann Simoneau, Director of Compliance and Enforcement Office at CTP, stated:

 

The ban action today should serve as a clear reminder to all manufacturers that if they continue to sell illegal products, we will fully leverage the power of the law. The FDA is committed to collaborating with federal partners, including the Department of Justice, to enforce the law.

 

The FDA has announced that it has taken action against manufacturers, distributors, importers, and retailers of illegal e-cigarette products over the past year. As of November 2023, the FDA has issued approximately 640 warning letters to companies involved in the production and/or distribution of illegal e-cigarette products and devices. In addition, over 400 warning letters have been sent to retailers selling unauthorized e-cigarettes, and civil penalty complaints have been filed against 36 e-cigarette manufacturers and 42 retailers for manufacturing and/or selling unauthorized products.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
ZYN by IQOS to Roll Out Across Tokyo From May 11 Through IQOS Shops and Lawson
Philip Morris Japan announced on April 23 at a product briefing that ZYN by IQOS, an oral tobacco pouch previously launched in selected areas, will expand sales in Tokyo. The company said the product will be released progressively from May 11 through IQOS shops, Lawson and other outlets in the city. The launch will include four flavors, each offered in Low and Medium intensity levels, for a total of eight products.
Apr.27 by 2FIRSTS.ai
From Heating Blades to Heating Paper? CTHB Patent Points to Microwave Heated Tobacco Design
From Heating Blades to Heating Paper? CTHB Patent Points to Microwave Heated Tobacco Design
According to China’s patent office records, a patent owned by China Tobacco Hubei Industrial Corporation (CTHB) for “cigarette paper and a cigarette for microwave heating” was granted on May 19, 2026. The patent describes cigarette paper with an outer wrapping layer, a heating layer, and an isolation heat-conducting layer, allowing it to absorb microwave energy, convert it to heat, and transfer that heat to the aerosol-generating substrate.
Jun.10
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
FDA Expands ENDS Market Access With First Authorization of Non-Tobacco and Non-Menthol Products
The U.S. Food and Drug Administration (FDA) announced on May 5, 2026 that it authorized the marketing of four Glas electronic nicotine delivery system (ENDS) products through the premarket tobacco product application (PMTA) pathway. The authorized products are Classic Menthol, Fresh Menthol, Gold and Sapphire pods, each containing 50mg/ml, or 5%, tobacco-derived nicotine.
May.06 by 2FIRSTS.ai
EU Launches Online Feedback as TPD Revision Enters New Milestone
EU Launches Online Feedback as TPD Revision Enters New Milestone
The European Commission has opened an online call for evidence on revising EU tobacco products and advertising rules, marking a new phase in the TPD/TAD review. Policy options may cover novel products, flavours, packaging, digital marketing and advertising. A 2Firsts review of 855 early submissions shows rapid engagement and recurring debate over differentiated regulation, harm reduction, youth protection, illicit trade and economic impact.
Special Report
May.21
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
China Tobacco Hubei Industrial Patent Discloses Nicotine Tooth Patch for Fixed Oral Delivery
According to Chinese patent records, a “nicotine tooth patch” application filed by China Tobacco Hubei Industrial Corporation (CTHB) and Hubei Xinye Tobacco Sheet Development Co., Ltd. was published on May 19, 2026. The filing proposes a nicotine gel patch that adheres to the tooth surface, especially the lingual side, to reduce displacement, foreign-body sensation, and accidental swallowing risks associated with existing oral nicotine products.
Jun.10
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
AP Questions FDA Rationale as Glas Fruit-Flavored Vapes Won Authorization Without Added Cessation Benefit
The U.S. Food and Drug Administration (FDA) recently authorized two fruit-flavored vaping products from Glas, but a newly released agency memo shows the products did not demonstrate greater smoking-cessation benefits than tobacco-flavored e-cigarettes. The Associated Press said the findings are likely to raise further questions about the FDA’s regulatory rationale and standards for flavored vaping products.
Jun.12